Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
4.560
-0.130 (-2.77%)
At close: May 26, 2026, 4:00 PM EDT
4.660
+0.100 (2.19%)
Pre-market: May 27, 2026, 5:10 AM EDT

Achieve Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
468265122874474
Market Cap Growth
474.39%116.70%40.01%98.88%-40.38%48.57%
Enterprise Value
453.81239.3597.5771.6619.1545.45
Last Close Price
4.564.973.524.122.457.78
PB Ratio
22.7412.305.84-60.225.282.62
P/TBV Ratio
20.5410.075.40-56.413.132.25
Debt / Equity Ratio
0.870.520.470.000.010.53
Net Debt / Equity Ratio
-1.34-1.00-1.17-0.82-1.03-1.00
Net Debt / EBITDA Ratio
0.270.390.63-0.040.210.85
Net Debt / FCF Ratio
0.320.430.82-0.050.230.95
Quick Ratio
2.474.015.140.751.159.49
Current Ratio
2.624.395.460.821.279.80
Return on Equity (ROE)
-322.95%-257.67%-409.51%-869.88%-233.04%-101.49%
Return on Assets (ROA)
-139.93%-136.48%-134.71%-110.45%-105.31%-75.37%
Return on Invested Capital (ROIC)
19962.30%15076.90%3740.45%1090000.00%31751.00%-4098.33%
Return on Capital Employed (ROCE)
-194.15%-169.75%-256.12%-786.44%-158.95%-82.40%
Buyback Yield / Dilution
-39.99%-35.93%-61.75%-87.18%-30.46%-198.64%
Total Shareholder Return
-39.99%-35.93%-61.75%-87.18%-30.46%-198.64%
Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q